The UK stock market has recently faced challenges, with the FTSE 100 index experiencing a downturn influenced by weak trade data from China, highlighting global economic uncertainties. In such volatile times, dividend stocks can offer a more stable income stream for investors seeking to navigate these fluctuations while maintaining exposure to potential long-term growth.
| Name | Dividend Yield | Dividend Rating |
| Telecom Plus (LSE:TEP) | 5.88% | ★★★★★☆ |
| Pollen Street Group (LSE:POLN) | 6.90% | ★★★★★☆ |
| Multitude (LSE:0R4W) | 10.19% | ★★★★★☆ |
| MONY Group (LSE:MONY) | 6.25% | ★★★★★★ |
| James Halstead (AIM:JHD) | 6.61% | ★★★★★☆ |
| IG Group Holdings (LSE:IGG) | 3.54% | ★★★★★☆ |
| Dunelm Group (LSE:DNLM) | 7.85% | ★★★★★☆ |
| BTG Consulting (AIM:BTG) | 4.30% | ★★★★★☆ |
| Arbuthnot Banking Group (AIM:ARBB) | 6.39% | ★★★★★☆ |
| 4imprint Group (LSE:FOUR) | 3.63% | ★★★★★☆ |
Click here to see the full list of 46 stocks from our Top UK Dividend Stocks screener.
Let's explore several standout options from the results in the screener.
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: Conduit Holdings Limited, with a market cap of £656.99 million, operates through its subsidiary to offer reinsurance products and services across the United States, Europe, and globally.
Operations: Conduit Holdings Limited generates revenue from its reinsurance business through three primary segments: Casualty ($262.40 million), Property ($348.30 million), and Specialty ($120.40 million).
Dividend Yield: 6%
Conduit Holdings Limited recently reported a significant turnaround with net income of US$80.3 million for H1 2026, up from a loss last year, and declared an interim dividend of $0.18 per share. Despite its high dividend yield in the top 25% of UK payers, Conduit's dividends have been volatile over five years without growth. However, dividends are well-covered by earnings and cash flow, indicating sustainability despite forecasted earnings decline.
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a variety of generic, specialty, and branded pharmaceutical products with a market cap of £3.47 billion.
Operations: Hikma Pharmaceuticals' revenue is primarily derived from its Injectables segment at $1.43 billion, followed by Hikma Rx at $1.04 billion, and Branded products contributing $914 million.
Dividend Yield: 3.8%
Hikma Pharmaceuticals offers a stable dividend history over the past decade, but its current 3.77% yield is below the UK market's top quartile. The company's payout ratio of 48.6% suggests earnings coverage, yet cash flow coverage remains inadequate at a 92.5% cash payout ratio. Recent strategic moves include share buybacks worth $226 million and plans for acquisitions in Europe, which may impact future dividend sustainability and growth potential amidst its high debt levels.
Simply Wall St Dividend Rating: ★★★★★★
Overview: MONY Group plc operates in the United Kingdom, offering price comparison and lead generation services through its websites and applications, with a market cap of £1.03 billion.
Operations: MONY Group plc generates revenue through its segments in Money (£110.50 million), Cashback (£49.30 million), Insurance (£236.90 million), and Home Services (£54.80 million).
Dividend Yield: 6.3%
MONY Group's dividend strategy is supported by a stable history of payouts over the past decade, with a current yield of 6.25%, placing it in the top quartile of UK dividend payers. The company's recent interim dividend increase reflects strong cash conversion and confidence in future prospects. Dividends are sustainably covered by earnings (80.9% payout ratio) and cash flows (71.2% cash payout ratio). Recent share buybacks worth £16.5 million further demonstrate financial robustness and shareholder value focus.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com